CUBT — Curative Biotechnology Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
- $14.62m
- $15.47m
2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 0 | 0.161 | 0.67 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0 | 0.07 | 0.025 |
Prepaid Expenses | |||
Total Current Assets | 0 | 2.13 | 0.754 |
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.003 | 0.002 | 0.007 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 0.04 | 2.27 | 2.41 |
Payable / Accrued | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.125 | 0.665 | 0.73 |
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 0.125 | 0.665 | 0.73 |
Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | -0.085 | 1.61 | 1.68 |
Total Liabilities & Shareholders' Equity | 0.04 | 2.27 | 2.41 |
Total Common Shares Outstanding | |||
Total Preferred Shares Outstanding |